Lonza Group’s Large-Scale Fill & Finish Facility for Commercial Drug Products Building Plan

Lenz & Staehelin advised Lonza in this transaction. Bär & Karrer acted as legal advisor to Novartis.SIX-listed Lonza Group AG announced that it plans to construct…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Federica Tiefenthaler

Author: Federica Tiefenthaler

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here